-
Loading metrics
Ex Vivo Treatment with a Novel Synthetic Aminoglycoside NB54 in Primary Fibroblasts from Rett Syndrome Patients Suppresses MECP2 Nonsense Mutations
- Manuela Vecsler,
- Bruria Ben Zeev,
- Igor Nudelman,
- Yair Anikster,
- Amos J. Simon,
- Ninette Amariglio,
- Gideon Rechavi,
- Timor Baasov,
- Eva Gak
x
- Published: June 13, 2011
- https://doi.org/10.1371/journal.pone.0020733